OurPet's Reaches Settlement With Competitor Over OurPet's Play-N-Squeak(R) Patent


FAIRPORT HARBOR, OH--(Marketwire - May 31, 2011) - OurPet's Company (OTCBB: OPCO) (www.ourpets.com), a leading proprietary pet supply company today announced a patent infringement settlement. In April 2011, OurPet's filed a patent infringement lawsuit in the United States District Court for the Northern District of Ohio against Sergeant's Pet Care Products, Inc. (Case No. 1:11-cv-743). In the lawsuit, OurPet's alleged that Sergeant's engaged in conduct that infringed upon OurPet's Utility Patent 6,371,053 ('053 patent), which is for a simulated mouse toy having a prerecorded sound chip and sold by OurPet's under the Play-N-Squeak® label. The parties recently reached a resolution. Under the settlement, Sergeant's has agreed to terminate sales of its Zoink! Chatty Mouse products after an agreed wind-down period in which Sergeant's will sell its remaining inventory under a license agreement with OurPet's. OurPet's was represented by David A. Welling of Choken Welling LLP, Akron, Ohio, and Sergeant's was represented by Keith J. Grady of Polsinelli Shughart PC, St. Louis, Missouri.

About OurPet's Company: OurPet's designs, produces and markets a broad line of innovative, high-quality accessory and consumable pet products in the US and overseas. Investors and customers may visit www.ourpets.com for more information about the Company and its products. The Company's websites include: www.smartscoop.com, www.ecopurenaturals.com, www.playnsqueak.com, and www.flappydogtoys.com.

Certain of the matters set forth in this press release are forward-looking and involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially are the following: business conditions and growth in the industry; general economic conditions; addition or loss of significant customers; the loss of key personnel; product development; competition; risks of doing business abroad; foreign government regulations; fluctuations in foreign rates; rising costs of raw materials and the unavailability of sources of supply; the timing of orders booked; and the other risks that are described from time to time in OurPet's SEC reports.

Contact Information:

CONTACT:
OurPet's Company
Dr. Steven Tsengas
CEO
(440) 354-6500 (Ext. 111)

INVESTOR RELATIONS:
Robert A. Lentz and Associates, Inc.
Robert Lentz
(614) 876-2000